Synapse - Guido Dalbagni

Results (47)

Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets

Journal Article

Pietzak, E. J.; Bagrodia, A.; Cha, E. K.; Drill, E. N.; Iyer, G.; Isharwal, S.; Ostrovnaya, I.; Baez, P.; Li, Q.; Berger, M. F.; more...
European Urology (2017)

Fulltext@MSK | Save

Correlation of DNA damage response (DDR) gene alterations with response to neoadjuvant (neo) dose-dense gemcitabine and cisplatin (ddGC) in urothelial carcinoma (UC)

Meeting Abstract

Iyer, G.; Balar, A. V.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Multicenter prospective phase II trial of neoadjuvant (neo) dose dense gemcitabine and cisplatin (DD-GC) in patients (pts) with muscle-invasive bladder cancer (MIBC)

Meeting Abstract

Balar, A. V.; Iyer, G.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer

Journal Article

Al-Ahmadie, H. A.; Iyer, G.; Lee, B. H.; Scott, S. N.; Mehra, R.; Bagrodia, A.; Jordan, E. J.; Gao, S. P.; Ramirez, R.; Cha, E. K.; more...
Nature Genetics (2016)

Fulltext@MSK | Save

Comprehensive molecular analysis of plasmacytoid variant urothelial carcinoma

Meeting Abstract

Al-Ahmadie, H. A.; Iyer, G.; Lee, B. H.; Scott, S. N.; Mehra, R.; Bagrodia, A.; Jordan, E. J.; Gao, S. P.; Ramirez, R.; Cha, E. K.; more...
Modern Pathology (2016)

Fulltext@MSK | Save

Comprehensive molecular analysis of plasmacytoid variant urothelial carcinoma

Meeting Abstract

Al-Ahmadie, H. A.; Iyer, G.; Lee, B. H.; Scott, S. N.; Mehra, R.; Bagrodia, A.; Jordan, E. J.; Gao, S. P.; Ramirez, R.; Cha, E. K.; more...
Laboratory Investigation (2016)

Fulltext@MSK | Save

Examining the genomic differences between upper and lower tract urothelial carcinomas

Meeting Abstract

Scott, S. N.; Sfakianos, J. P.; Cha, E. K.; Iyer, G.; Zabor, E. C.; Kim, P. H.; Hakimi, A. A.; Ostrovnaya, I.; Ramirez, R.; Hanrahan, A. J.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Genomic characterization of upper tract urothelial carcinoma

Journal Article

Sfakianos, J. P.; Cha, E. K.; Iyer, G.; Scott, S. N.; Zabor, E. C.; Shah, R. H.; Ren, Q.; Bagrodia, A.; Kim, P. H.; Hakimi, A. A.; more...
European Urology (2015)

Fulltext@MSK | Save

Gemcitabine-cisplatin (GC) plus radical cystectomy-pelvic lymph node dissection (RC-PLND) for patients (pts) with muscle-invasive bladder cancer (MIBC): Assessing impacts of neoadjuvant chemotherapy (NAC) and the PLND

Meeting Abstract

Tully, C. M.; Bochner, B. H.; Dalbagni, G.; Zabor, E. C.; Herr, H. W.; Donat, S. M.; Ostrovnaya, I.; Regazzi, A. M.; Kim, P. H.; Sfakianos, J. P.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Phase II trial of neoadjuvant gemcitabine (G) and cisplatin (C) with sunitinib in patients (pts) with muscle-invasive bladder cancer (MIBC)

Meeting Abstract

Balar, A. V.; Iyer, G.; Apolo, A. B.; Regazzi, A. M.; Garcia-Grossman, I. R.; Pendse, D.; Ostrovnaya, I.; Chou, J. F.; Bochner, B.; Dalbagni, G.; more...
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save